Gerresheimer AG (GXI) - Total Assets
Based on the latest financial reports, Gerresheimer AG (GXI) holds total assets worth €4.76 Billion EUR (≈ $5.56 Billion USD) as of May 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gerresheimer AG - Total Assets Trend (2013–2024)
This chart illustrates how Gerresheimer AG's total assets have evolved over time, based on quarterly financial data. Also see market value of Gerresheimer AG for the company's overall valuation and market capitalisation.
Gerresheimer AG - Asset Composition Analysis
Current Asset Composition (November 2024)
Gerresheimer AG's total assets of €4.76 Billion consist of 26.1% current assets and 74.0% non-current assets. Review debt load of Gerresheimer AG to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.9% |
| Accounts Receivable | €310.64 Million | 8.2% |
| Inventory | €349.74 Million | 9.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €564.82 Million | 14.8% |
| Goodwill | €676.35 Million | 17.8% |
Asset Composition Trend (2013–2024)
This chart illustrates how Gerresheimer AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Gerresheimer AG for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gerresheimer AG's current assets represent 26.1% of total assets in 2024, a decrease from 30.1% in 2013.
- Cash Position: Cash and equivalents constituted 4.9% of total assets in 2024, up from 4.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, a decrease from 34.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 17.8% of total assets.
Gerresheimer AG Competitors by Total Assets
Key competitors of Gerresheimer AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Gerresheimer AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.01 | 0.87 | 0.61 |
| Quick Ratio | 0.56 | 0.51 | 0.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €8.04 Million | €-136.46 Million | €-351.54 Million |
Gerresheimer AG - Advanced Valuation Insights
This section examines the relationship between Gerresheimer AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.48 |
| Latest Market Cap to Assets Ratio | 0.19 |
| Asset Growth Rate (YoY) | 11.1% |
| Total Assets | €3.81 Billion |
| Market Capitalization | $710.83 Million USD |
Valuation Analysis
Below Book Valuation: The market values Gerresheimer AG's assets below their book value (0.19x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Gerresheimer AG's assets grew by 11.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Gerresheimer AG (2013–2024)
The table below shows the annual total assets of Gerresheimer AG from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-11-30 | €3.81 Billion ≈ $4.45 Billion |
+11.08% |
| 2023-11-30 | €3.43 Billion ≈ $4.01 Billion |
+2.23% |
| 2022-11-30 | €3.35 Billion ≈ $3.92 Billion |
+16.57% |
| 2021-11-30 | €2.88 Billion ≈ $3.36 Billion |
+9.97% |
| 2020-11-30 | €2.62 Billion ≈ $3.06 Billion |
-0.93% |
| 2019-11-30 | €2.64 Billion ≈ $3.09 Billion |
-3.28% |
| 2018-11-30 | €2.73 Billion ≈ $3.19 Billion |
+11.74% |
| 2017-11-30 | €2.44 Billion ≈ $2.86 Billion |
+2.94% |
| 2016-11-30 | €2.37 Billion ≈ $2.78 Billion |
-1.87% |
| 2015-11-30 | €2.42 Billion ≈ $2.83 Billion |
+46.11% |
| 2014-11-30 | €1.66 Billion ≈ $1.94 Billion |
+2.49% |
| 2013-11-30 | €1.62 Billion ≈ $1.89 Billion |
-- |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more